Your account is not claimed yet. You can sign up with ORCID to claim your account.

Liguo Wang (L Wang)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 21

Top Venues

Nature communications

Cancer research

Proceedings of the National Academy of Sciences of the United States of America

BMC bioinformatics

Mayo Clinic Minnesota

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Minnesota

United States

Assistant Professor :: Division of Biomedical Statistics and Informatics

Publications

Donglin Ding, Alexandra M Blee, Jianong Zhang, Yunqian Pan, Nicole A Becker, L James Maher, Raphael E Jimenez, Liguo Wang, Zhenlin Huang
Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis. Nature communications 14 (1) (2023)
Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia-Longarte, Won-Min Song, Naoto Fujiwara, Peiyao Li, Isabel Mendizabal, Daniel P Petrylak, William Kevin Kelly, E Premkumar Reddy, Liguo Wang, Matthew J Schiewer, Amaia Lujambio, Robert Jeffrey Karnes, Beatrice Knudsen, Carlos Cordon-Cardo, Haidong Dong, Zhenlin Huang, Arkaitz Carracedo, Yujin Hoshida, Veronica Rodriguez-Bravo, Josep Domingo-Domenech
Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer. Cancer discovery (2023)
Jamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, Dawei Jiang, Anupama Singh, Katherine R Kaufmann, David J Niles, Erika Heninger, Nicholas R Rydzewski, Liguo Wang, Liewei Wang, Rendong Yang, Yanan Ren, Johnathan W Engle, Peng Huang, Christos E Kyriakopoulos, Susan F Slovin, Howard R Soule, Shuang G Zhao, Manish Kohli, Scott T Tagawa, Weibo Cai, Scott M Dehm, Joshua M Lang
Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Tao Ma, Lingyun Guo, Huihuang Yan, Liguo Wang
Cobind: quantitative analysis of the genomic overlaps. Bioinformatics advances 3 (1) (2023)
Rui Sun, Binyuan Yan, Hao Li, Dongling Ding, Liguo Wang, Jun Pang, Dingwei Ye, Zhenlin Huang
Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis. Cancer research (2023)
Donglin Ding, Rongbin Zheng, Ye Tian, Raphael E Jimenez, Xiaonan Hou, Saravut J Weroha, Liguo Wang, Lei Shi, Zhenlin Huang
Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer. Nature communications 13 (1) (2022)
Connor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, Ricky Tsai, Warren Winick-Ng, Minggao Liang, Ahmad Malik, Judy Pawling, Silvana B De Lorenzo, Asma Ali, Paul A Decker, Matt L Kosel, Arijit Panda, Khalid N Al-Zahrani, Lingyan Jiang, Jared W L Browning, Chris Lowden, Michael Geuenich, J Javier Hernandez, Jessica T Gosio, Musaddeque Ahmed, Sampath Kumar Loganathan, Jacob Berman, Daniel Trcka, Kulandaimanuvel Antony Michealraj, Jerome Fortin, Brittany Carson, Ethan W Hollingsworth, Sandra Jacinto, Parisa Mazrooei, Lily Zhou, Andrew J Elia, Mathieu Lupien, Housheng Hansen He, Daniel J Murphy, Liguo Wang, Alexej Abyzov, James W Dennis, Philipp G Maass, Kieran Campbell, Michael D Wilson, Daniel H Lachance, Margaret Wrensch, John Wiencke, Tak Wah Mak, Len A Pennacchio, Diane E Dickel, Axel Visel, Jeffrey L Wrana, Michael D Taylor, Gelareh Zadeh, Peter B Dirks, Jeanette E Eckel-Passow, Liliana Attisano, Ana Pombo, Cristiane M Ida, Evgeny Z Kvon, Robert B Jenkins, Daniel Schramek
A noncoding single-nucleotide polymorphism at 8q24 drives IDH1 -mutant glioma formation. Science (New York, N.Y.) 378 (6615) (2022)
Rui Sun, Ting Wei, Donglin Ding, Jianong Zhang, Sujun Chen, Housheng Hansen He, Liguo Wang, Haojie Huang
CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (39) (2022)
Ting Wei, Jinfu Nie, Nicholas B Larson, Zhenqing Ye, Jeanette E Eckel-Passow, Keith D Robertson, Jean-Pierre A Kocher, Liguo Wang
CpGtools: a python package for DNA methylation analysis. Bioinformatics (Oxford, England) 37 (11) (2021)
Ting Wei, Ji Lu, Tao Ma, Haojie Huang, Jean-Pierre Kocher, Liguo Wang
Re-Evaluate Fusion Genes in Prostate Cancer. Cancer informatics 20 (2021)
Dejie Wang, Jian Ma, Maria Victoria Botuyan, Gaofeng Cui, Yuqian Yan, Donglin Ding, Yingke Zhou, Eugene W Krueger, Jiang Pei, Xiaosheng Wu, Liguo Wang, Huadong Pei, Mark A McNiven, Dingwei Ye, Georges Mer, Zhenlin Huang
ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication. Science advances 7 (25) (2021)
Bo Tang, Rui Sun, Dejie Wang, Haoyue Sheng, Ting Wei, Liguo Wang, Jun Zhang, Thai H Ho, Lu Yang, Qiang Wei, Haojie Huang
ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer. Proceedings of the National Academy of Sciences of the United States of America 118 (8) (2021)
Jianong Zhang, Kun Gao, Hongyan Xie, Dejie Wang, Pingzhao Zhang, Ting Wei, Yuqian Yan, Yunqian Pan, Wenbin Ye, Huifen Chen, Qing Shi, Yao Li, Shi-Min Zhao, Xiaonan Hou, Saravut J Weroha, Yuzhuo Wang, Jun Zhang, R Jeffrey Karnes, Housheng Hansen He, Liguo Wang, Chenji Wang, Zhenlin Huang
SPOP mutation induces DNA methylation via stabilizing GLP/G9a. Nature communications 12 (1) (2021)
Jian Ma, Qing Shi, Gaofeng Cui, Haoyue Sheng, Maria Victoria Botuyan, Yingke Zhou, Yuqian Yan, Yundong He, Liguo Wang, Yuzhuo Wang, Georges Mer, Dingwei Ye, Chenji Wang, Zhenlin Huang
SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition. Nature communications 12 (1) (2021)
Zhenlin Huang, Bo Tang, Yinhui Yang, Zhaogang Yang, Lei Shi, Yang Bai, Binyuan Yan, R Jeffrey Karnes, Jun Zhang, Rafael Jimenez, Liguo Wang, Qiang Wei, Jinjian Yang, Wanhai Xu, Zhankui Jia, Zhenlin Huang
MAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression. Cancer research 81 (17) (2021)
Yundong He, Ting Wei, Zhenqing Ye, Jacob J Orme, Dong Lin, Haoyue Sheng, Ladan Fazli, R Jeffrey Karnes, Raphael E Jimenez, Liguo Wang, Liewei Wang, Martin E Gleave, Yuzhuo Wang, Lei Shi, Zhenlin Huang
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer. Nature communications 12 (1) (2021)
Yingke Zhou, Xin Jin, Jian Ma, Donglin Ding, Zhenlin Huang, Haoyue Sheng, Yuqian Yan, Yunqian Pan, Ting Wei, Liguo Wang, Heshui Wu
HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer. Cancer research 81 (6) (2021)
Pingzhao Zhang, Dejie Wang, Yu Zhao, Shancheng Ren, Kun Gao, Zhenqing Ye, Shangqian Wang, Chun-Wu Pan, Yasheng Zhu, Yuqian Yan, Yinhui Yang, Di Wu, Yundong He, Jun Zhang, Daru Lu, Xiuping Liu, Long Yu, Shimin Zhao, Yao Li, Dong Lin, Yuzhuo Wang, Liguo Wang, Yu Chen, Yinghao Sun, Chenji Wang, Haojie Huang
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation. Nature medicine 23 (9) (2017)
Zhenqing Ye, Tao Ma, Michael T Kalmbach, Surendra Dasari, Jean-Pierre A Kocher, Liguo Wang
CircularLogo: A lightweight web application to visualize intra-motif dependencies. BMC bioinformatics 18 (1) (2017)
X Jin, Y Pan, Liguo Wang, L Zhang, R Ravichandran, P R Potts, J Jiang, H Wu, H Huang
MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation. Oncogenesis 6 (4) (2017)
Yundong He, Shihong Peng, Jinhua Wang, Huang Chen, Xiaonan Cong, Ang Chen, Meichun Hu, Min Qin, Haigang Wu, Shuman Gao, Liguo Wang, Xin Wang, Zheng-Fang Yi, Mingyao Liu
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer. Nature communications 7 (2016)

Liguo Wang.css-eqlu8i{font-size:small;padding-left:4px;} (L Wang)

Publication Activity (10 Years)

Top Topics

Top Venues

Liguo Wang (L Wang)